VIRAL HEPATITIS
Clinical trials for VIRAL HEPATITIS explained in plain language.
Never miss a new study
Get alerted when new VIRAL HEPATITIS trials appear
Sign up with your email to follow new studies for VIRAL HEPATITIS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Which hepatitis b pill is safer for kidneys? new trial aims to find out
Disease control Recruiting nowThis study compares two common antiviral drugs, tenofovir alafenamide (TAF) and entecavir (ETV), in adults with chronic hepatitis B. The goal is to see which one better controls the virus and protects kidney function. About 140 participants will be randomly assigned to one of the…
Matched conditions: VIRAL HEPATITIS
Phase: PHASE4 • Sponsor: Taichung Veterans General Hospital • Aim: Disease control
Last updated May 17, 2026 05:32 UTC
-
New hope for hepatitis d patients: combo therapy aims to clear virus where current drug falls short
Disease control Recruiting nowThis study tests whether a combination of two experimental drugs, tobevibart and elebsiran, can clear the hepatitis D virus in people who still have detectable virus despite taking bulevirtide. About 150 adults with chronic hepatitis D will receive the combo and be followed for u…
Matched conditions: VIRAL HEPATITIS
Phase: PHASE3 • Sponsor: Vir Biotechnology, Inc. • Aim: Disease control
Last updated May 13, 2026 16:01 UTC